These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22579111)

  • 21. Antiangiogenic isoforms of vascular endothelial growth factor predominate in subretinal fluid of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Ricker LJ; Dieudonné SC; Kessels AG; Rennel ES; Berendschot TT; Hendrikse F; Kijlstra A; La Heij EC
    Retina; 2012 Jan; 32(1):54-9. PubMed ID: 21836532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical therapeutic results of rhegmatogenous retinal detachment associated with choroidal detachment].
    Zhu J; Xu X; Zhang X
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):135-9. PubMed ID: 11955315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased levels of soluble syndecan-1 in the subretinal fluid and the vitreous of eyes with rhegmatogenous retinal detachment.
    Wang JB; Tian CW; Guo CM; Du HJ; Liu HL; Zhang YJ; Hui YN
    Curr Eye Res; 2008 Jan; 33(1):101-7. PubMed ID: 18214747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
    Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between IL-1 beta and TNF-alpha in subretinal fluids of rhegmatogenous retinal detachment with PVR].
    Chen B; Jiand D; Huang P; Tang L
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(5):483-5. PubMed ID: 10682568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
    Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activities of trypsin-like serine proteases and their inhibitors in blood and subretinal fluid of patients with different stages of proliferative vitreoretinopathy in rhegmatogenous retinal detachment].
    Katsnel'son LA; Chesnokova NB; Antelava ND
    Vestn Oftalmol; 2000; 116(1):24-6. PubMed ID: 10741259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High subretinal fluid procoagulant activity in rhegmatogenous retinal detachment.
    Ricker LJ; Dieri RA; Beckers GJ; Pels E; Liem AT; Hendrikse F; Kijlstra A; Hemker HC; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5234-9. PubMed ID: 20435588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of retinal detachment subretinal fluid on extracellular matrix metabolism.
    González-Avila G; Méndez D; Lozano D; Ramos C; Delgado J; Iturria C
    Ophthalmologica; 2004; 218(1):49-56. PubMed ID: 14688436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA Expression in Subretinal Fluid in Eyes Affected by Rhegmatogenous Retinal Detachment.
    Carpineto P; Di Filippo ES; Aharrh Gnama A; Bondi D; Iafigliola C; Licata AM; Fulle S
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment.
    Hoerster R; Hermann MM; Rosentreter A; Muether PS; Kirchhof B; Fauser S
    Br J Ophthalmol; 2013 Apr; 97(4):450-3. PubMed ID: 23355528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
    Becher N; Hein M; Uldbjerg N; Danielsen CC
    Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
    Chen YS; Langhammer T; Westhofen M; Lorenzen J
    Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study.
    Sanabria Ruiz-Colmenares MR; Pastor Jimeno JC; Garrote Adrados JA; Telleria Orriols JJ; Yugueros Fernández MI
    Acta Ophthalmol Scand; 2006 Jun; 84(3):309-13. PubMed ID: 16704689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
    Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
    Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.